Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-11 6:28 pm Sale |
2024-09-30 | 13G | Cogent Biosciences, Inc. COGT |
Venrock Healthcare Capital Partners II, L.P. | 6,446,917 5.800% |
-5,069,750 (-44.02%) |
Filing History |
| 2025-02-14 6:04 pm Sale |
2024-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Venrock Healthcare Capital Partners II, L.P. | 1,266,457 1.400% |
-6,410,477 (-83.50%) |
Filing History |
| 2024-11-14 5:51 pm Purchase |
2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI |
Venrock Healthcare Capital Partners II, L.P. | 7,676,934 9.990% |
969,370 (+14.45%) |
Filing History |
| 2024-11-14 5:49 pm Sale |
2024-09-30 | 13G | Lyra Therapeutics, Inc. LYRA |
Venrock Healthcare Capital Partners II, L.P. | 1,204,094 1.800% |
-4,349,458 (-78.32%) |
Filing History |
| 2024-11-14 5:48 pm Purchase |
2024-09-30 | 13G | Instil Bio, Inc. TIL |
Venrock Healthcare Capital Partners II, L.P. | 33,177 0.500% |
33,177 (New Position) |
Filing History |
| 2024-11-14 5:47 pm Purchase |
2024-09-30 | 13G | Cogent Biosciences, Inc. COGT |
Venrock Healthcare Capital Partners II, L.P. | 11,516,667 9.990% |
2,477,823 (+27.41%) |
Filing History |
| 2024-02-14 8:56 pm Purchase |
2023-12-31 | 13G | DBV Technologies S.A. DBVT |
Venrock Healthcare Capital Partners II, L.P. | 482,733 9.990% |
12,559 (+2.67%) |
Filing History |
| 2024-02-14 8:47 pm Purchase |
2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Venrock Healthcare Capital Partners II, L.P. | 6,707,564 9.990% |
395,372 (+6.26%) |
Filing History |
| 2024-02-14 8:46 pm Sale |
2023-12-31 | 13G | Annexon, Inc. ANNX |
Venrock Healthcare Capital Partners II, L.P. | 968,679 1.200% |
-3,960,321 (-80.35%) |
Filing History |
| 2024-02-14 8:35 pm Sale |
2023-12-31 | 13G | Savara Inc. SVRA |
Venrock Healthcare Capital Partners II, L.P. | 3,500,000 2.600% |
-2,851,531 (-44.90%) |
Filing History |
| 2024-02-14 8:35 pm Purchase |
2023-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Venrock Healthcare Capital Partners II, L.P. | 5,553,552 9.999% |
2,120,284 (+61.76%) |
Filing History |
| 2024-02-14 8:34 pm Sale |
2023-12-31 | 13G | GH Research PLC GHRS |
Venrock Healthcare Capital Partners II, L.P. | 1,318,327 2.500% |
-2,198,798 (-62.52%) |
Filing History |
| 2024-02-14 8:34 pm Sale |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Venrock Healthcare Capital Partners II, L.P. | 0 0.000% |
-3,867,749 (Position Closed) |
Filing History |
| 2024-02-14 8:33 pm Purchase |
2023-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Venrock Healthcare Capital Partners II, L.P. | 9,038,844 9.990% |
1,729,716 (+23.67%) |
Filing History |
| 2024-02-14 8:32 pm Sale |
2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Venrock Healthcare Capital Partners II, L.P. | 0 0.000% |
-4,563,962 (Position Closed) |
Filing History |
| 2023-02-14 5:11 pm Sale |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
Venrock Healthcare Capital Partners II, L.P. | 0 0.000% |
-2,333,975 (Position Closed) |
Filing History |
| 2023-02-14 4:55 pm Purchase |
2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Venrock Healthcare Capital Partners II, L.P. | 6,312,192 9.990% |
2,643,858 (+72.07%) |
Filing History |
| 2023-02-14 4:55 pm Purchase |
2022-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Venrock Healthcare Capital Partners II, L.P. | 7,309,128 9.990% |
3,007,002 (+69.90%) |
Filing History |
| 2023-02-14 4:40 pm Purchase |
2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Venrock Healthcare Capital Partners II, L.P. | 3,433,268 9.999% |
218 (+0.01%) |
Filing History |
| 2023-02-14 4:31 pm Purchase |
2022-12-31 | 13G | DBV Technologies S.A. DBVT |
Venrock Healthcare Capital Partners II, L.P. | 470,174 9.990% |
33 (+0.01%) |
Filing History |